118 related articles for article (PubMed ID: 3406040)
21. Effects of 2-indolecarbohydrazides on thromboxane synthetase activity and on in vitro and ex vivo blood platelet aggregation. New selective inhibitors.
Monge A; Erro A; Parrado P; Font M; Aldana I; Rocha E; Fernandez-Alvarez E
Arzneimittelforschung; 1986 Aug; 36(8):1184-6. PubMed ID: 3096343
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.
Sprague PW; Heikes JE; Gougoutas JZ; Malley MF; Harris DN; Greenberg R
J Med Chem; 1985 Nov; 28(11):1580-90. PubMed ID: 4067988
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin biosynthetic activities of isolated fetal lamb ductus arteriosus, other blood vessels, and lung tissue.
Skidgel RA; Friedman WF; Printz MP
Pediatr Res; 1984 Jan; 18(1):12-8. PubMed ID: 6583652
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme.
Haurand M; Ullrich V
J Biol Chem; 1985 Dec; 260(28):15059-67. PubMed ID: 2999104
[TBL] [Abstract][Full Text] [Related]
25. Effects of ONO-3122 (an enhancer of PGH2 production) and OKY-1581 (an inhibitor of TXA2 production) on the vasopressin-induced water flow in the toad bladder.
Marumo F
Pharmacology; 1985; 31(1):34-9. PubMed ID: 3927326
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiological role of thromboxane A2 and pharmacological approaches to its inhibition.
Patscheke H; Hornberger W; Zehender H
Z Kardiol; 1990; 79 Suppl 3():151-4. PubMed ID: 2099038
[TBL] [Abstract][Full Text] [Related]
27. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
[No Abstract] [Full Text] [Related]
28. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
Quilley J; McGiff JC; Nasjletti A
Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
[TBL] [Abstract][Full Text] [Related]
29. Some new prospects in the mechanism of control of arachidonate metabolism in human placenta and amnion.
Dembélé-Duchesne MJ; Thaler-Dao H; Chavis C; de Paulet AC
Prostaglandins; 1981 Dec; 22(6):979-1002. PubMed ID: 6801732
[No Abstract] [Full Text] [Related]
30. Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery.
Mayeux PR; Kadowitz PJ; McNamara DB
Biochim Biophys Acta; 1989 Mar; 1011(1):18-24. PubMed ID: 2493809
[TBL] [Abstract][Full Text] [Related]
31. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
Basevich VV; Mevkh AT; Varfolomeev SD
Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin endoperoxide metabolism by microsomes of whole kidneys from normal, congenital unilateral hydronephrotic and unilateral ureteral obstructed rats.
McNamara DB; Boineau FG; McMullen-Laird M; Lippton HL; She HS; Lewy JE; Kadowitz PJ
Prostaglandins; 1982 Nov; 24(5):585-605. PubMed ID: 6962465
[No Abstract] [Full Text] [Related]
33. Biosynthesis of thromboxane B2 and 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Evidence for a common enzymatic pathway.
Raz A; Aharony D; Kenig-Wakshal R
Eur J Biochem; 1978 May; 86(2):447-54. PubMed ID: 658053
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel arachidonic acid metabolites formed by prostaglandin H synthase.
Hecker M; Ullrich V; Fischer C; Meese CO
Eur J Biochem; 1987 Nov; 169(1):113-23. PubMed ID: 3119336
[TBL] [Abstract][Full Text] [Related]
35. Purification of thromboxane synthetase and evidence of two distinct mechanisms for the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid by porcine lung microsomes.
Hall ER; Tai HH
Biochim Biophys Acta; 1981 Sep; 665(3):498-503. PubMed ID: 7197552
[TBL] [Abstract][Full Text] [Related]
36. Constriction of cat coronary arteries by synthetic thromboxane A2 and its antagonism.
Smith JB; Yanagisawa A; Zipkin R; Lefer AM
Prostaglandins; 1987 Jun; 33(6):777-82. PubMed ID: 3671730
[TBL] [Abstract][Full Text] [Related]
37. Regulation of lymphatic contractility by arachidonate metabolites.
Johnston MG; Gordon JL
Nature; 1981 Sep; 293(5830):294-7. PubMed ID: 7196995
[No Abstract] [Full Text] [Related]
38. Macrophages isolated from liver granulomas of murine Schistosoma mansoni synthesize predominantly TxA2 during the acute and chronic phases of infection.
Tripp CS; Needleman P; Kassab JT; Weinstock JV
J Immunol; 1988 May; 140(9):3140-3. PubMed ID: 3129511
[TBL] [Abstract][Full Text] [Related]
39. Thromboxane synthase inhibition and perinatal pulmonary response to arachidonic acid.
Tod ML; Cassin S
J Appl Physiol (1985); 1985 Mar; 58(3):710-6. PubMed ID: 3920192
[TBL] [Abstract][Full Text] [Related]
40. Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase.
Watanabe K; Iguchi Y; Iguchi S; Arai Y; Hayaishi O; Roberts LJ
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1583-7. PubMed ID: 3456602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
